Leading Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LEADING PHARMA, and what generic and branded alternatives to LEADING PHARMA drugs are available?
LEADING PHARMA has two approved drugs.
Drugs and US Patents for Leading Pharma
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Leading Pharma | LACOSAMIDE | lacosamide | SOLUTION;ORAL | 216461-001 | Feb 6, 2023 | AA | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Leading Pharma | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 217151-002 | Jul 25, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Leading Pharma | VARENICLINE TARTRATE | varenicline tartrate | TABLET;ORAL | 217151-001 | Jul 25, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.